Focused immediate action on the highest-impact weaknesses.

Strengthening Cybersecurity for a Biotech Company
Risk clarity for a growing genetic medicine company.
The work begins with the operating reality.
A biotechnology company operating across clinical development, cloud services, laboratories, and core infrastructure.
EngagementA fast-growing clinical-stage genetic medicine company needed an evidence-based view of risk across a large research and technology environment.
What had to change
Rapid growth had expanded the attack surface beyond earlier assessments. Sensitive research, intellectual property, and regulated systems were spread across roughly 2,300 internal IP addresses and 27 external IP addresses.
The client needed current evidence of exploitable weaknesses and a practical remediation order without disrupting the daily work of research and clinical teams.
How the work came together
BlueAlly performed comprehensive internal and external penetration testing, combining automated discovery with manual validation to confirm real impact and reduce false positives.
Security engineers documented reproducible evidence, assigned risk ratings, and provided specific remediation guidance across access, email, TLS, hosts, services, and network behavior.
What changed
The assessment identified three critical-risk, six high-risk, and six medium-risk vulnerabilities. The client gained a prioritized roadmap for addressing the issues most likely to affect research data, core systems, and compliance posture.
Findings included paths to unauthorized access and email spoofing exposure, allowing the organization to strengthen access controls, harden email policy, and improve audit readiness.
What the client gained.
Created a clear remediation order backed by evidence.
Reduced paths to sensitive research data and core services.
Connected technical remediation to regulatory resilience.
More outcomes in Cybersecurity
Have a similar constraint?
We can start with the current state, the outcome, and the limits around time, risk, and budget.


